Duration of immunity (DOI) and booster vaccination--dealing with the issue at practice level in the UK

Human Healthcare and Its Pharmacy Component from a Safety Point of View

Healthcare plays a crucial role in public and national safety as a significant part of state activity and a component of national safety, whose mission is to organize and ensure affordable medical care for the population. The four stages of the genesis of healthcare safety development with the corresponding safety models of formation were defined: technical, human factor or security management, systemic security management, and cognitive complexity. It was established that at all stages, little attention is paid to the issues of the formation of the pharmaceutical sector's safety. Taking into account the development of safety models that arise during the four stages of the genesis of safety science, we have proposed a model of the evolution of pharmaceutical safety formation. At the same time, future research is proposed to focus on new holistic concepts of safety, such as "Safety II", evaluation and validation methods, especially in the pharmaceutical sector, where the development of this topic remained in the second stage of the evolution of science, the search for pharmaceutical errors related to drugs.

Survey of veterinary surgeons on the introduction of serological testing to assess revaccination requirements

Despite the discussion of the use of serological testing in canine vaccination protocols, no study has been published that investigates the opinions of the veterinary profession regarding the use of the test to assess revaccination requirements in dogs. This paper presents the results of a study designed to fill this research gap which was completed in 2009. Veterinary surgeons were asked to complete a questionnaire on different aspects of canine vaccination and the introduction of serological testing to determine revaccination requirements. Of the 448 questionnaires distributed, 243 replies were received (54.2 per cent) and of these, a significant majority (169/243; 69.5 per cent) of respondents would consider introducing serological testing. An average of 53.5 per cent of respondents practised tri-annual revaccination for the core diseases. A significant number of respondents (86/140; 61 per cent) who placed low importance on vaccine overload would consider introducing serological testing into canine vaccination programmes (P=0.002).